Camel tears show promise in neutralizing snake venom, study finds

A landmark study conducted by researchers in Dubai suggests that camel tears may offer groundbreaking potential in neutralizing snake venom.

The research, led by the Central Veterinary Research Laboratory (CVRL) in Dubai, tested camelid antibodies derived from both tears and blood plasma.

When camels were immunized with venom from snakes such as the saw-scaled viper, the extracted antibodies demonstrated the ability to counteract venom-induced hemorrhage and coagulation disorders in preclinical trials.

These camelid antibodies are also reportedly smaller, more heat-stable, and less likely to trigger allergic reactions than traditional horse-based antivenoms.

Snakebite envenomation remains a critical global health issue. According to the World Health Organization, approximately 5.4 million people are bitten annually, causing up to 138,000 deaths and countless long-term disabilities.

India bears the heaviest burden, with an estimated 58,000 deaths per year.

While the findings are compelling, researchers emphasize the need for peer-reviewed validation and progression to human clinical trials.

Further development is required to confirm efficacy, optimal dosing, and safety in real-world applications.

Camel tears may not literally neutralize snake venom, but the study does highlight the remarkable potential of camelid antibodies in the fight against a global health crisis.